comparemela.com

Latest Breaking News On - Santhera pharmaceuticals - Page 6 : comparemela.com

Santhera Receives Approval for AGAMREE® (Vamorolone) as a Treatment for Duchenne Muscular Dystrophy in the United Kingdom

Santhera Receives Approval for AGAMREE® (Vamorolone) as a Treatment for Duchenne Muscular Dystrophy in the United Kingdom
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United-states
Pratteln
Switzerland-general
Switzerland
Germany
United-kingdom
Swiss
America
Eva-kalias
Shabir-hasham
Life-science-alliance
European-union

Santhera Receives Approval for AGAMREE® (Vamorolone) as a

Approval by the Medicines and Healthcare products Regulatory Agency (MHRA) of AGAMREE® in the United Kingdom follows marketing authorization for this.

Switzerland
United-states
United-kingdom
Germany
Pratteln
Switzerland-general
America
Swiss
Shabir-hasham
Eva-kalias
European-medicines-agency
America-to-catalyst-pharmaceuticals

Top 5 Most-Read DMD Articles of 2023

This year’s top content in the Duchenne muscular dystrophy (DMD) space focused on a novel gene therapy approval, the high cost of care for this genetic disorder, and steps forward in other treatments.

United-states
American
Sarah-boyce
Health-care-resource-utilization
Santhera-pharmaceuticals
American-journal
Treat-duchenne-muscular
Biosciences-gains
Drug-designation
Patients-with
Avidity-biosciences
Patient-death-following-high-dose-gene-therapy

vimarsana © 2020. All Rights Reserved.